Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3557 |  WHWK Whitehawk Therapeutics, Inc. - Common Stock | 3.47 USD | +1.76% | -8.92% | -15.98% | +15.28% | 197.82 M USD | ||
| 3558 |  ACOG Alpha Cognition Inc. - Common Stock | 9.04 USD | 0.00% | +3.91% | +1.23% | +18.48% | 196.87 M USD | ||
| 3560 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 2.42 USD | 0.00% | -2.42% | -12.95% | -18.79% | 196.65 M USD | ||
| 3563 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 70.34 USD | -2.24% | -3.49% | +1.35% | +75.94% | 195.98 M USD | ||
| 3573 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 3.81 USD | +2.14% | +4.38% | -4.51% | -57.53% | 192.61 M USD | ||
| 3606 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 2.51 USD | -1.57% | -4.92% | -32.89% | +36.41% | 179.90 M USD | ||
| 3611 |  DTIL Precision BioSciences, Inc. - Common Stock | 6.43 USD | +2.88% | +0.16% | -10.20% | +9.35% | 177.48 M USD | ||
| 3615 |  ANTX AN2 Therapeutics, Inc. - Common Stock | 4.68 USD | -3.51% | -17.02% | -15.83% | +274.40% | 176.61 M USD | ||
| 3617 |  CMPX Compass Therapeutics, Inc. - Common Stock | 0.98 USD | -3.92% | +4.26% | -54.42% | -75.92% | 176.49 M USD | ||
| 3623 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.20 USD | -3.89% | -7.28% | -11.39% | +76.47% | 174.71 M USD | ||
| 3638 |  PYXS Pyxis Oncology, Inc. - Common Stock | 1.99 USD | -1.00% | -9.95% | -41.81% | -48.04% | 165.98 M USD | ||
| 3641 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 1.57 USD | -3.68% | -4.85% | -19.90% | -37.45% | 165.42 M USD | ||
| 3642 |  CHRS Coherus Oncology, Inc. - Common Stock | 1.07 USD | +5.94% | -10.08% | -19.55% | -33.54% | 165.32 M USD | ||
| 3643 |  PEPG PepGen Inc. - Common Stock | 2.38 USD | -0.83% | +6.25% | -23.96% | -51.43% | 164.84 M USD | ||
| 3648 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.18 USD | +4.42% | -10.61% | -36.22% | -39.18% | 163.17 M USD | ||
| 3652 |  CUE Cue Biopharma, Inc. - Common Stock | 22.33 USD | -0.80% | -12.77% | -26.06% | +2301.08% | 162.21 M USD | ||
| 3664 |  MDWD MediWound Ltd. - Ordinary Shares | 12.42 USD | -3.35% | -8.81% | -9.61% | -33.01% | 159.41 M USD | ||
| 3666 |  NKTX Nkarta, Inc. - Common Stock | 2.22 USD | -2.20% | -14.62% | -22.92% | -5.93% | 159.01 M USD | ||
| 3668 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.37 USD | 0.00% | +2.24% | -17.96% | -69.62% | 158.07 M USD | ||
| 3673 |  TARA Protara Therapeutics, Inc. - Common Stock | 2.65 USD | +2.32% | -5.69% | -30.26% | -53.51% | 156.60 M USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |